Yes — your consultation allows us to understand your goals, health history, and lifestyle before recommending a plan.

Results vary by individual and lifestyle. Our focus is on sustainable, steady progress — not quick fixes.

FDA-approved products that contain these active ingredients (such as Wegovy®, Ozempic®, and Rybelsus® for Semaglutide; and Saxenda® for Liraglutide) have been reviewed and approved by the FDA for specific medical uses.

When prescribed in compounded form, these medications are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs. At Gloss Aesthetics, compounded versions are used only when an FDA-approved product is unavailable or clinically unsuitable for a specific patient. All compounded prescriptions are prepared by state-licensed compounding pharmacies and prescribed under professional medical supervision with close patient monitoring.

No — our approach focuses on balance, not restriction. We guide you through achievable changes that support your long-term health.

Liraglutide is a once-daily medication within the GLP-1 family. It helps support healthy appetite regulation and digestion, working best when paired with lifestyle and nutritional changes under professional guidance.

Liraglutide may cause mild nausea, fatigue, or stomach discomfort at the beginning of treatment. These typically improve as your body adjusts. At Gloss, your provider will guide you through each step and monitor your comfort closely throughout your journey.

Semaglutide is a GLP-1 medication clinically shown to support weight loss by reducing appetite, slowing digestion, and helping regulate blood sugar.

Common side effects can include mild nausea, bloating, or constipation — typically temporary as your body adjusts. Our providers monitor you closely and make dosage adjustments as needed to ensure comfort and safety.

Tirzepatide is a dual-acting medication that works on two natural pathways — GLP-1 and GIP — to help support appetite control and metabolic balance. It’s administered weekly and is part of a provider-guided plan that emphasizes gradual, sustainable results.

Mild nausea, constipation, or changes in appetite can occur as your body adapts. These effects are typically short-lived. Our team monitors your progress and tailors your treatment plan to help minimize discomfort while supporting your wellness goals.

Medical weight loss is a clinician-guided approach to weight management that uses medical evaluation, individualized treatment recommendations, and ongoing monitoring to help eligible patients achieve and maintain weight-loss goals.

At Gloss Medical Aesthetics & Laser, medical weight management is individualized rather than based on a one-size-fits-all program. Your medical history, current medications, weight history, previous weight-loss attempts, lifestyle, goals, and potential risk factors are considered when determining whether treatment is appropriate.

Gloss offers medically supervised weight-management options for eligible patients, which may include Semaglutide or Tirzepatide-based treatment when clinically appropriate and legally available. The appropriate treatment depends on your medical history, current medications, previous weight-management efforts, treatment goals, contraindications, and other clinical factors. Medication is prescribed only after an appropriate medical evaluation.

Semaglutide and tirzepatide belong to classes of medications that act on hormones involved in appetite, satiety, and metabolic regulation. Semaglutide works through the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors. When used as part of an appropriate medical weight-management program, these medications may help reduce appetite, increase feelings of fullness, and support reduced caloric intake. Medication works best as part of a broader strategy that includes sustainable nutrition, physical activity, sleep, and other healthy lifestyle behaviors.

Both medications can be used for chronic weight management in appropriate patients, but they work somewhat differently. Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GIP and GLP-1 receptors. They also differ in dosing, clinical evidence, FDA-approved products and indications, potential side effects, and how individual patients respond.

Eligibility for prescription weight-management medication is determined through an individualized medical assessment. FDA-approved chronic weight-management medications generally have specific eligibility criteria involving body mass index (BMI) and, in some cases, the presence of weight-related medical conditions. However, BMI alone does not determine whether a medication is safe or appropriate. Your provider will also review your health history, current medications, previous treatment attempts, contraindications, and overall goals before making a recommendation.

Common side effects can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, indigestion, and decreased appetite. Gastrointestinal symptoms may be more noticeable when beginning treatment or following a dose increase.

Laboratory testing may be recommended depending on your medical history, symptoms, current medications, previous laboratory results, and proposed treatment. Testing can help your provider evaluate aspects of your overall metabolic health and identify medical considerations that could affect your treatment plan.

Yes. Prescription medication can be a powerful tool, but sustainable weight management involves more than medication alone. Adequate nutrition, physical activity, resistance training when appropriate, sufficient protein intake, hydration, sleep, and sustainable behavioral changes can all play important roles in supporting weight loss and preserving overall health.

Weight regain can occur after discontinuing weight-management medication. Obesity is increasingly treated as a chronic condition, and appetite-regulating biological mechanisms may change when medication is stopped. This is why long-term planning is an important part of medical weight management. Depending on your circumstances, your provider may discuss ongoing treatment, lifestyle strategies, maintenance planning, or alternative approaches.

Yes. Many people seeking medical weight management have already attempted dietary changes, exercise programs, or other weight-loss strategies.Difficulty achieving or maintaining weight loss does not necessarily mean that someone simply needs to “try harder.” Body weight is influenced by multiple biological, behavioral, environmental, hormonal, and metabolic factors.

A medical evaluation can help determine whether prescription treatment may be an appropriate additional tool for your weight-management plan.

Follow-up frequency depends on your treatment plan and clinical needs. Regular monitoring allows your provider to evaluate weight trends, medication effectiveness, side effects, adherence, and whether dose adjustments are appropriate. More frequent monitoring may be necessary when beginning medication or adjusting doses.